Dickinson brings nearly 20 years’ industry experience to the role and will build on Quantum’s position as a leading specials supplier in the UK. His career has spanned chromatography research with ICI, quality assurance at Cussons International, management at 3M Healthcare and a role developing pharmaceutical, healthcare and beauty products in Africa. Latterly, he was head of quality and compliance at Perrigo (formerly Galpharm).
Quantum Pharmaceutical is a pharmaceutical specials manufacturer licensed by the UK MHRA to supply pharmacies, chemists, dispensing doctors and hospitals with bespoke medicines.
Quantum Pharmaceutical appoints quality director
Brings 20 years’ experience to the role
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months